Obesity and Antiphospholipid Syndrome: A Particular Challenge in Pregnancy
Obesity Research - Open Journal · 2015
DOI: 10.17140/oroj-2-109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Research - Open Journal, 2015. Verfasst von Karoline Mayer-Pickel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Obesity is associated with a broad spectrum of chronic diseases, as well as cardiovascular diseases, such as diabetes, dyslipidemia, insulin resistance and hyperglycemia. Obesityduring pregnancy is of major concern due to the well-known risk factors for both the motherand the child. Complications in pregnancy include recurrent miscarriages, gestational diabetes, hypertensive disorders, thromboembolism, and stillbirth. Additionally, maternal obesityseems to have long-term consequences for offspring, predisposing or “programming” them tothe development of metabolic disease in adulthood. Antiphospholipid syndrome (APS) is anautoimmune disease and is characterized by the presence of antiphospholipid antibodies (anticardiolipin antibodies/ACLA, lupus antikoagulans/LA and ß2-glycoprotein) in the maternalcirculation. These antibodies are associated with arterial and/or venous thromboses and withadverse obstetric outcomes such as recurrent fetal loss, Preeclampsia (PE), Intrauterine growthrestriction (IUGR) and Intrauterine fetal death (IUFD).Obesity and APS are both chronic diseases with similar, even long-term consequencesfor mother and child; a co-occurrence of obesity and APS in pregnancy worsens the situation;the use of novel therapeutical tools should be therefore encouraged. A better understandingof the complex interactions between endothelial dysfunction and obesity and APS should befurther investigated. Obese women with known APS should be counselled before conceptionnot only about potential obstetrical complications as well as the long-term consequences for theoff-spring, but also about these important life-style modifications. This review will provide anoverview of obesity and APS in pregnancy and will discuss endothelial dysfunction as mechanism for adverse obstetric outcome in these chronic diseases.
Zitieren
APA
Mayer-Pickel, K. (2015). Obesity and Antiphospholipid Syndrome: A Particular Challenge in Pregnancy. Obesity Research - Open Journal. https://doi.org/10.17140/oroj-2-109
Vancouver
Mayer-Pickel K. Obesity and Antiphospholipid Syndrome: A Particular Challenge in Pregnancy. Obesity Research - Open Journal. 2015. doi:10.17140/oroj-2-109
BibTeX
@article{MayerPickel2015,
author = {Mayer-Pickel, Karoline},
title = {Obesity and Antiphospholipid Syndrome: A Particular Challenge in Pregnancy},
journal = {Obesity Research - Open Journal},
year = {2015},
doi = {10.17140/oroj-2-109}
}
EUVIMED